Authors/Disclosures
|
Vern C. Juel, MD, FAAN
(Duke University Medical Center)
|
Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accordant Health Services. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network. |
|
Lisa Hobson-Webb, MD, FAAN
(Duke University Medical Center)
|
An immediate family member of Dr. Hobson-Webb has received personal compensation for serving as an employee of G1 Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. The institution of Dr. Hobson-Webb has received research support from Sanofi Genzyme. |
|
Edward C. Smith, MD
(Rare Disease Research - NC, LLC)
|
No disclosure on file |
|
David E. Stickler, MD
|
No disclosure on file |
|
Manish Modi
|
No disclosure on file |
|
Duygu Selcen, MD, FAAN
(Mayo Clinic)
|
Dr. Selcen has nothing to disclose. |
|
|
No disclosure on file |